Navigation Links
Common cold virus may kill breast cancer cells

University of Newcastle researcher Kathryn Skelding, funded by the National Breast Cancer Foundation and Viralytics Ltd, has been working on a new treatment which only affects cancer cells ?this would be an improvement on conventional chemotherapy and radiation treatment, which also impact on normal body cells.

"In theory, the virus is able to selectively target and destroy many different types of cancer cells, including breast cancers, whilst leaving normal cells unaffected," she said.

Debilitating symptoms associated with conventional treatments (such as nausea, vomiting and hair loss) could also be avoided by using the Coxsackie virus.

"If this research is successful we could have something that produces side effects as harmless as a mild, common cold-like infection yet it could successfully treat breast cancer," Ms Skelding said.

Latest research to be revealed at Canberra briefing

The Skelding project, and other ground-breaking research, will be discussed at the NBCF Annual Breakfast Briefing, a series of national events to communicate with the Foundation's corporate and general public supporters.

In Canberra, the breakfast briefing will be held on Thursday March 22 at Parliament house.

University of Wollongong's Professor Don Iverson will report on the progress of breast cancer research in Australia. His presentation will highlight achievements, and the way ahead for breast cancer research in order to have the greatest impact on the disease.

The NBCF has thrown its weight behind a National Action Plan for Breast Cancer Research and Funding, developing sustainable research collaborations, which could halve the time it will take to answer the big questions in breast cancer.

National Breast Cancer Foundation CEO Ms Sue Murray said NBCF funds are directed to the best research in Australia, unlimited by state boundaries.

"The NBCF is committed to funding the Australian res earch that will have the biggest impact on the prevention and treatment of breast cancer. This research will be translated into benefits for all Australians, regardless of which State the research is conducted in." Ms Murray said.


'"/>

Source:Research Australia


Related biology news :

1. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
2. Harmful Bacterium Commonly Found in Poultry May Survive Refrigeration and Frozen Storage Combined
3. Men Estimate Mens Risks Of Common Disorders Higher Than Women Do, And Vice Versa
4. Use of Antibiotics for Acne May Increase Risk of Common Illness
5. Common viruses may cause cancer
6. Common alternative treatment for liver disease is found to be ineffective
7. Common molecular signature identified in solid tumors
8. Common bacteria pirate natural mechanism to get inside cells
9. Commonly used antidepressants may also affect human immune system
10. Common practices at petting zoos put visitors at risk
11. Common enzyme is a key player in DNA repair
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/7/2017)... , March 7, 2017 Brandwatch , the leading ... The Prince,s Trust to uncover insights to support its ... Trust. The UK,s leading youth charity will be using ... results and get a better understanding of the topics and issues ... ...
(Date:3/2/2017)... , March 2, 2017 Summary This ... Perrigo and its partnering interests and activities since 2010. ... Read the ... and Alliance since 2010 report provides an in-depth insight into ... sciences companies. On demand company reports are prepared ...
(Date:3/2/2017)... 2017 Australian stem cell and regenerative medicine ... signed an agreement with the Monash Lung Biology Network, ... Institute and Department of Pharmacology at Monash University, ... study to support the use of Cymerus™ mesenchymal stem ... Asthma is a chronic, long term lung condition ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... ... March 21, 2017 , ... The Conference Forum has announced the launch of ... on May 10-11, 2017, at the Colonnade Hotel in Boston, MA. The CMO Summit ... peer-to-peer learning, benchmarking and support. , “The Chief Medical Officer faces a unique set ...
(Date:3/22/2017)... Milwaukee, WI (PRWEB) , ... March 22, 2017 , ... ... federal scientific research agencies as outlined in the Administration’s recently published fiscal year 2018 ... for the National Institutes of Health (NIH) by $5.8 billion or roughly 20% of ...
(Date:3/22/2017)... , March 22, 2017  Personal Genome ... its cancer testing contract with the U.S. Department ... tumor profiling assay with the company,s new CancerSELECT ... comprehensive, clinically actionable pan-cancer profiling test that includes ... assess potential patient response to checkpoint inhibitor immunotherapies. ...
(Date:3/20/2017)... ... , ... SSCI and Whitehouse Laboratories, divisions of Albany Molecular Research, Inc, are ... the Parenteral Drug Association (PDA), the New York Interphex Show will open on March ... more than 625 exhibitors, the educational and networking opportunities are extremely valuable. INTERPHEX is ...
Breaking Biology Technology: